Description: Bloomage BioTechnology Corporation Limited researchers, develops, produces, and sells bioactive materials. It offers pharmaceutical grade sodium hyaluronate which can be used as an API or excipient for drugs and medical devices in ophthalmic preparations, intra-articular injections, anti-adhesive preparations, and topical preparations for wound healing and soft tissue filler under the Hyature name; and cosmetic grade sodium hyaluronate solutions for cosmetic products, including moisturizing, repairing, delay skin aging, and brightening under the Hybloom, miniHA, microHA, Hyacross, Hyacolor, and cationHA. The company also provides food-grade sodium hyaluronate for use in food/healthy food/dietary supplements under the HAPLEX name, as well as food-grade gamma aminobutyric acid under the Gabarelax name; hyaluronic acid for oral care under the Biomoist name; and animal care products under the HYAPET names. Bloomage BioTechnology Corporation Limited was founded in 2000 and is headquartered in Jinan, the People's Republic of China.
Home Page: www.bloomagebioactive.com
Tech Development Zone
Jinan,
250101
China
Phone:
86 531 8268 5998
Officers
| Name | Title |
|---|---|
| Ms. Yan Zhao | Chairman & GM |
| Mr. Luan Yizheng | Deputy GM & Chief Financial Officer |
| Mr. Jiajun Guo | Deputy GM & Director |
| Mr. Xueping Guo | Deputy GM of Core Technician & Director |
| Ms. Aihua Liu | Deputy GM of Core Technician & Director |
| Ms. Aihua Wang | Exec. Director |
| Ms. Guixin Xu | Deputy Gen. Mang. |
| Mr. Yihong Luan | Deputy Gen. Mang. of Core Technician |
| Ms. Lingli Lin | Deputy GM & Director |
| Mr. Yizheng Li | Deputy GM, Sec. of the Board of Directors & Director |
Exchange: SHG
Country: CN
Currency: Renminbi (¥)
| Forward PE: | 46.0829 |
|---|---|
| Trailing PE: | 72.6313 |
| Price-to-Book MRQ: | 9.8766 |
| Price-to-Sales TTM: | 9.9194 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 3214 |